University of Warwick Featured PhD Programmes
University of Auckland Featured PhD Programmes
National University of Ireland, Galway Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Max Planck Society Featured PhD Programmes

Novel Approaches to the Emergency Management of Hyperkalaemia

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Dr T Hiemstra
  • Application Deadline
    No more applications being accepted
  • Competition Funded PhD Project (European/UK Students Only)
    Competition Funded PhD Project (European/UK Students Only)

Project Description

As part of the Experimental Medicine Training Initiative, this is a prestigious fully-funded, clinical PhD Studentship at the University of Cambridge. This innovative initiative is a partnership between the University of Cambridge, Cambridge Biomedical Research Centre and Pharmaceutical Companies. The Studentship is available from April 2018, and provides an unrivalled opportunity to undertake high quality clinical research in the area of nephrology and clinical pharmacology, in collaboration with AstraZeneca. It will appeal to clinical trainees from a wide range of disciplines including Clinical Pharmacology, Nephrology and Acute Medicine. The Studentship award will cover a clinical stipend for 3 years, University and College fees, and a generous training allowance.

This project is a unique opportunity to join a collaboration between the Division of Experimental Medicine and Immunotherapeutics at the University of Cambridge, and the Renal division at AstraZeneca.
The remit will be to study the epidemiology, sequelae and treatment of hyperkalaemia with particular reference to the emergency setting. Existing treatments have important limitations. Novel treatment options exist, and the studentship will be focused on the design and conduct of epidemiological, physiological and proof of concept studies to develop novel approaches to the emergency management of hyperkalaemia.
Working closely with leading investigators in the Division of Experimental Medicine and Immunotherapeutics from the University of Cambridge, the Cambridge Clinical Trials Unit and AstraZeneca, you will apply the findings of these studies to the design of a late phase emergency medicine trial.
This project will provide you with an opportunity to apply your strengths to emergency, renal and experimental medicine, and will provide a unique hands-on perspective of translational medicine. The successful applicant will be offered the opportunity to spend time with AstraZeneca and international academic collaborators. The structured mentoring and training environment will allow the candidate to develop as an academic clinician with expertise in designing and conducting experimental medicine studies and later phase trials.

Funding Notes

The Studentship award will cover a clinical stipend for 3 years, University and College fees, and a generous training allowance

References

Two

How good is research at University of Cambridge in Clinical Medicine?

FTE Category A staff submitted: 192.05

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Let us know you agree to cookies

We use cookies to give you the best online experience. By continuing, we'll assume that you're happy to receive all cookies on this website. To read our privacy policy click here

Ok